Identification
- Composition (DCI)
- déférasirox
- Manufacturer
- NOVARTIS PHARMA MAROC
- ATC code
- V03AC03
- Presentation
- Boîte de 28
- Schedule / Reimb.
- A
- Hospital price
- 2523.00 MAD
Indications
Traitement des hémosidéroses post-transfusionnelles. Traitement de la surcharge en fer chronique nécessitant un traitement chélateur chez les patients à partir de 10 ans présentant une thalassémie non dépendante des transfusions. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About EXJADE 250 MG
EXJADE 250 MG is marketed in Morocco by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of EXJADE 250 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about EXJADE 250 MG
Answers to common questions from Moroccan patients about this drug.